In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery
- Resource Type
- Authors
- Sema Arisoy; Deniz Önal; Tansel Comoglu; Özgün Sayiner; Bilge Pehlivanoglu; Ozbeyen Atalay
- Source
- Pharmaceutical Development and Technology. 25:735-747
- Subject
- Drug
Levodopa
business.industry
media_common.quotation_subject
Dopaminergic
Pharmaceutical Science
02 engineering and technology
General Medicine
Nose to brain
Pharmacology
021001 nanoscience & nanotechnology
030226 pharmacology & pharmacy
In vitro
nervous system diseases
03 medical and health sciences
PLGA
chemistry.chemical_compound
0302 clinical medicine
chemistry
In vivo
medicine
0210 nano-technology
business
medicine.drug
media_common
- Language
- ISSN
- 1097-9867
1083-7450
Parkinson’s disease (PD) is a neurodegenerative disease which is characterized by the loss of dopaminergic neurons in the brain. Levodopa is the drug of choice in the treatment of PD but it exhibit...